DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $501,057 | -46.0% | 24,854 | 0.0% | 0.01% | -44.4% |
| Q2 2021 | $927,551 | +24.9% | 24,854 | -14.4% | 0.01% | +28.6% |
| Q1 2021 | $742,425 | +16.1% | 29,035 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $639,641 | +22.5% | 29,035 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $522,340 | -29.2% | 29,035 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $737,489 | +75.7% | 29,035 | +27.0% | 0.01% | +33.3% |
| Q1 2020 | $419,828 | -16.6% | 22,854 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $503,474 | +26.2% | 22,854 | -17.8% | 0.01% | 0.0% |
| Q3 2019 | $399,021 | -8.8% | 27,787 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $437,643 | +37.6% | 27,787 | +28.0% | 0.01% | +25.0% |
| Q1 2019 | $318,066 | +37.0% | 21,711 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $232,091 | -29.9% | 21,711 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $331,310 | +24.6% | 21,711 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $266,000 | – | 21,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |